A preliminary study performed on BC patients carrying germline ATM missense variants or small deletions in both exonic and intronic regions showed that p53-MCL was impaired, highlighting its potentiality for the detection of ATM pathogenic mutations also in BC [84]. The gene discussed is ATM; the disease is breast cancer.